September 18, 2018 – Washington, DC – Today, Friends of Cancer Research (Friends) announced the launch of Phase II of its tumor mutational burden or TMB Harmonization Project as the TMB harmonization team finalizes data collected from the Phase I in silico analysis.
Meet Friends of Cancer Research Advisory Advocate, Judy Fitzgerald! Judy is a breast cancer survivor, patient advocate, and a ProgressforPatients.org graduat…
Learn more about how we work through our Research Partnerships, Policy Initiatives, and Data Driven Insights & Analyses.
ProgressForPatients.org, an online advocacy education program and community working to help patients, advocates, and caregivers acquire the necessary tools to effectively communicate with drug researchers,…
Friends of Cancer Research Annual Meeting 2024 Tuesday, November 12, 2024 The Ritz Carlton 1150 22nd St NW, Washington, DC 20037 Conference will also be…
Friends of Cancer Research Annual Meeting 2024 Tuesday, November 12, 2024 The Ritz Carlton 1150 22nd St NW, Washington, DC 20037 Conference will also be…
ProgressForPatients.org, an online advocacy education program and community working to help patients, advocates, and caregivers acquire the necessary tools to effectively communicate with drug researchers,…
Friends of Cancer Research Annual Meeting 2024 Tuesday, November 12, 2024 The Ritz Carlton 1150 22nd St NW, Washington, DC 20037 Conference will also be…
What is Chevron deference, how did it come to be, and what were the implications for FDA? Chevron deference was established by the 1984 Supreme…
Friends of Cancer Research Annual Meeting 2024 Tuesday, November 12, 2024 The Ritz Carlton 1150 22nd St NW, Washington, DC 20037 Conference will also be…
Digital and Computational Pathology Tool Harmonization Project Quick Links Sign Up for Updates September 2023 White Paper Digital Pathology One Pager Project Outcomes The Digital…
